Cargando…

Protective role of antigenic sites on the envelope protein of Hantaan virus defined by monoclonal antibodies

To investigate the role of Hantaan virus envelope glycoprotein in infection, a panel of monoclonal antibodies (MAbs) was examined in vitro with several serological tests and in vivo by passive transfer experiments in mice. An antigenic site, specific for the inhibition of infected cell focus was det...

Descripción completa

Detalles Bibliográficos
Autores principales: Arikawa, J., Yao, J. -S., Yoshimatsu, K., Takashima, I., Hashimoto, N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 1992
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7087150/
https://www.ncbi.nlm.nih.gov/pubmed/1381911
http://dx.doi.org/10.1007/BF01309700
_version_ 1783509278077747200
author Arikawa, J.
Yao, J. -S.
Yoshimatsu, K.
Takashima, I.
Hashimoto, N.
author_facet Arikawa, J.
Yao, J. -S.
Yoshimatsu, K.
Takashima, I.
Hashimoto, N.
author_sort Arikawa, J.
collection PubMed
description To investigate the role of Hantaan virus envelope glycoprotein in infection, a panel of monoclonal antibodies (MAbs) was examined in vitro with several serological tests and in vivo by passive transfer experiments in mice. An antigenic site, specific for the inhibition of infected cell focus was detected with the focus inhibition neutralization test (FINT), in addition to the neutralization related antigenic sites, which were revealed by the ordinary focus reduction neutralization test (FRNT). Suckling mice were given the MAbs by passive transfer followed by lethal Hantaan virus challenge. All neutralizing MAbs detected by either FRNT or FINT protected all mice from lethal infection, confirming the importance of the antigenic sites as a protective antigen. Mice given non-neutralizing MAbs by passive transfer, however, began to die earlier than the control group; mean time to death (18.2±2.1 to 21.5±2.8 days) being significantly shorter than that of the control group (25.8±1.8, p<0.01, Mann-Whitney,U probability test). Virus titers in brains of mice which died early, were about 10 times higher than those of control mice. These results indicated the early death phenomenon of mice which was mediated by the antivirus antibody.
format Online
Article
Text
id pubmed-7087150
institution National Center for Biotechnology Information
language English
publishDate 1992
publisher Springer-Verlag
record_format MEDLINE/PubMed
spelling pubmed-70871502020-03-23 Protective role of antigenic sites on the envelope protein of Hantaan virus defined by monoclonal antibodies Arikawa, J. Yao, J. -S. Yoshimatsu, K. Takashima, I. Hashimoto, N. Arch Virol Original Papers To investigate the role of Hantaan virus envelope glycoprotein in infection, a panel of monoclonal antibodies (MAbs) was examined in vitro with several serological tests and in vivo by passive transfer experiments in mice. An antigenic site, specific for the inhibition of infected cell focus was detected with the focus inhibition neutralization test (FINT), in addition to the neutralization related antigenic sites, which were revealed by the ordinary focus reduction neutralization test (FRNT). Suckling mice were given the MAbs by passive transfer followed by lethal Hantaan virus challenge. All neutralizing MAbs detected by either FRNT or FINT protected all mice from lethal infection, confirming the importance of the antigenic sites as a protective antigen. Mice given non-neutralizing MAbs by passive transfer, however, began to die earlier than the control group; mean time to death (18.2±2.1 to 21.5±2.8 days) being significantly shorter than that of the control group (25.8±1.8, p<0.01, Mann-Whitney,U probability test). Virus titers in brains of mice which died early, were about 10 times higher than those of control mice. These results indicated the early death phenomenon of mice which was mediated by the antivirus antibody. Springer-Verlag 1992 /pmc/articles/PMC7087150/ /pubmed/1381911 http://dx.doi.org/10.1007/BF01309700 Text en © Springer-Verlag 1992 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Original Papers
Arikawa, J.
Yao, J. -S.
Yoshimatsu, K.
Takashima, I.
Hashimoto, N.
Protective role of antigenic sites on the envelope protein of Hantaan virus defined by monoclonal antibodies
title Protective role of antigenic sites on the envelope protein of Hantaan virus defined by monoclonal antibodies
title_full Protective role of antigenic sites on the envelope protein of Hantaan virus defined by monoclonal antibodies
title_fullStr Protective role of antigenic sites on the envelope protein of Hantaan virus defined by monoclonal antibodies
title_full_unstemmed Protective role of antigenic sites on the envelope protein of Hantaan virus defined by monoclonal antibodies
title_short Protective role of antigenic sites on the envelope protein of Hantaan virus defined by monoclonal antibodies
title_sort protective role of antigenic sites on the envelope protein of hantaan virus defined by monoclonal antibodies
topic Original Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7087150/
https://www.ncbi.nlm.nih.gov/pubmed/1381911
http://dx.doi.org/10.1007/BF01309700
work_keys_str_mv AT arikawaj protectiveroleofantigenicsitesontheenvelopeproteinofhantaanvirusdefinedbymonoclonalantibodies
AT yaojs protectiveroleofantigenicsitesontheenvelopeproteinofhantaanvirusdefinedbymonoclonalantibodies
AT yoshimatsuk protectiveroleofantigenicsitesontheenvelopeproteinofhantaanvirusdefinedbymonoclonalantibodies
AT takashimai protectiveroleofantigenicsitesontheenvelopeproteinofhantaanvirusdefinedbymonoclonalantibodies
AT hashimoton protectiveroleofantigenicsitesontheenvelopeproteinofhantaanvirusdefinedbymonoclonalantibodies